Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Oct 7, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Aug 12
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 8
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 8
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Lexicon Pharmaceuticals, Inc.
| 57.55M |
—
|
—
| +73.18% | 136.18M |
May 10
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Lexicon Pharmaceuticals, Inc.
| 8.03K |
—
|
—
| +19.91% | 48.36K |
Apr 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 8.03K |
—
|
—
| +5.05% | 167.06K |
Apr 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 8.03K |
—
|
—
| +19.91% | 48.36K |
Apr 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 8.03K |
—
|
—
| +0.60% | 1.35M |
Apr 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 8.03K |
—
|
—
| +10.09% | 87.65K |
Apr 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 8.03K |
—
|
—
| +3.34% | 248.36K |
Apr 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 1.15M |
$108.50 | $124,875,037.00 |
∞
| 1.15M |
Mar 13
| |||||||
Lexicon Pharmaceuticals, Inc.
| 17.45K |
$2.62 | -$30,897.66 | +57.50% | 47.8K | +1 |
Feb 28
| ||||||
Lexicon Pharmaceuticals, Inc.
| 59.87K |
$2.62 | -$98,750.42 | +22.65% | 324.21K |
Feb 28
| |||||||
Lexicon Pharmaceuticals, Inc.
| 24.22K |
$2.62 | -$58,753.50 | +85.03% | 52.69K | +1 |
Feb 28
| ||||||
Lexicon Pharmaceuticals, Inc.
| 43.14K |
$2.62 | -$63,948.96 | +20.29% | 255.72K | +1 |
Feb 28
| ||||||
Lexicon Pharmaceuticals, Inc.
| 43.05K |
$2.62 | -$63,804.86 | +35.98% | 162.67K | +1 |
Feb 28
| ||||||
Lexicon Pharmaceuticals, Inc.
| 32.44K |
$2.62 | -$81,914.30 | +213.64% | 47.63K | +1 |
Feb 28
| ||||||
Lexicon Pharmaceuticals, Inc.
| 42.7K |
$2.62 | -$67,082.48 | +31.68% | 177.5K | +1 |
Feb 28
| ||||||
Lexicon Pharmaceuticals, Inc.
| 183.71K |
$2.62 | -$160,792.02 | +20.09% | 1.1M |
Feb 28
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 8
| |||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 8
| ||||||
Lexicon Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 8
| |||||||
Lexicon Pharmaceuticals, Inc.
| 90K |
$1.05 | $94,797.00 | +10.92% | 914.36K |
Nov 16
| |||||||
Lexicon Pharmaceuticals, Inc.
| 200K |
$1.01 | $201,520.00 | +495.88% | 240.33K |
Nov 13
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.